HomeNewscoronavirusTom Hanks' COVID-19 diagnosis shaped public perception of virus: Study

Tom Hanks' COVID-19 diagnosis shaped public perception of virus: Study

The respondents who reported making changes said Hanks' disclosure inspired them to seek more information and/or take stricter precautions.

February 07, 2021 / 19:44 IST
Story continues below Advertisement
Tom Hanks
Tom Hanks

When award-winning actor Tom Hanks announced his Covid-19 diagnosis last year, many Americans were still learning about the virus and its severity. However, Hanks' social media posts shaped people's behaviour toward the virus, a new study suggests.

The researchers, including Jessica Gall Myrick from the Pennsylvania State University in the US, surveyed around 700 people about their attitudes and behaviours toward the virus the day after Hanks posted the news on social media on March 11, 2020.

Story continues below Advertisement

Just under 90 per cent of the people surveyed had heard about Hanks' social media posts saying he contracted the virus, and approximately half of that group reported it changed their attitudes and behaviours.

"There is a growing body of research about how celebrity behaviour and social media posts can affect public health," Myrick said in the study published in the journal Health Communication.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show